Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

NCT05238519 is registered in ClinicalTrials.gov with Essentia Health as lead sponsor.

NCT NCT05238519
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05238519 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)
Lead sponsor
Essentia Health
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2022
Completion date
August 21, 2025
Enrollment
257 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cholesterol, elevated, familial hypercholesterolemia, genetic disease